Approval · Notice of Compliance 2498 · 2001
CHOLEDYL EXPECTORANT ELIXIR: Notice of Compliance 2498
Issued January 30, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2498
- Date
- January 30, 2001
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Bronchodilator-expectorant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CHOLEDYL EXPECTORANT ELIXIR | 00476374 | Marketed |
Medicinal ingredients
- OXTRIPHYLLINE 100 MG per 5ML
- GUAIFENESIN 50 MG per 5ML